Database: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (European Union): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 140: | Line 140: | ||
<span style="display:none">hasDownloadableData::PDF</span> | <span style="display:none">hasDownloadableData::PDF</span> | ||
<span style="display:none">isDatabase</span> | <span style="display:none">isDatabase</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 11:17, 6 December 2025
Go back to European Union page
Type of Database: pharmacovigilance; registry; survey; clinical trial database; research study; administrative/claims data.
Primary purpose: To serve as a centralized electronic index for EU research organizations, networks, and data sources in the fields of pharmacoepidemiology and pharmacovigilance. It aims to facilitate connections between researchers and study sponsors by providing information on expertise and research experience across Europe. The databases allows users to identify relevant research centers, data sources, and patient registries based on various criteria.
Sponsor, manager or home institution: European Medicines Agency (EMA).
Type of information: cross-sectional; longitudinal. diagnosis; medication use; causes of death; medical procedures; devices; sex; age; region; healthcare costs; type of patient.
Data Dictionary: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.
Source of Information: The sources of the databases are provided and maintained by the listed organizations, data providers, or registry holders.
Data level: national level and regional level.
Number of Records: unknown.
Date range: unknown.
Cancer Areas of Interest: C00-D48: All neoplasms. Click here to learn more.
Data access: publicly available. Click here to access. Data can be downloaded in the PDF format.
Contact information: Click here to learn more.